These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35091236)

  • 21. Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.
    Ganesh T
    Expert Opin Ther Pat; 2015 Jul; 25(7):837-44. PubMed ID: 25772215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGE
    Liu Q; Liang X; Wang Q; Wilson EN; Lam R; Wang J; Kong W; Tsai C; Pan T; Larkin PB; Shamloo M; Andreasson KI
    Proc Natl Acad Sci U S A; 2019 May; 116(20):10019-10024. PubMed ID: 31036664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
    Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
    Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of second generation EP2 antagonists with high selectivity.
    Ganesh T; Jiang J; Dingledine R
    Eur J Med Chem; 2014 Jul; 82():521-35. PubMed ID: 24937185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice.
    Akhter MP; Cullen DM; Gong G; Recker RR
    Bone; 2001 Aug; 29(2):121-5. PubMed ID: 11502472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.
    Graham S; Gamie Z; Polyzois I; Narvani AA; Tzafetta K; Tsiridis E; Helioti M; Mantalaris A; Tsiridis E
    Expert Opin Investig Drugs; 2009 Jun; 18(6):746-66. PubMed ID: 19426119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E(2) receptors in bone formation.
    Li M; Thompson DD; Paralkar VM
    Int Orthop; 2007 Dec; 31(6):767-72. PubMed ID: 17593365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EP
    Bradbury P; Rumzhum NN; Ammit AJ
    J Cell Physiol; 2019 Jul; 234(7):11070-11077. PubMed ID: 30536718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
    Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery.
    Leclerc JL; Lampert AS; Diller MA; Immergluck JB; Doré S
    ASN Neuro; 2015; 7(2):. PubMed ID: 25873308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.
    Jiang J; Dingledine R
    J Pharmacol Exp Ther; 2013 Feb; 344(2):360-7. PubMed ID: 23192657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
    Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG
    Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
    Choudhary S; Alander C; Zhan P; Gao Q; Pilbeam C; Raisz L
    Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):35-40. PubMed ID: 18406186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
    Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.
    Li M; Ke HZ; Qi H; Healy DR; Li Y; Crawford DT; Paralkar VM; Owen TA; Cameron KO; Lefker BA; Brown TA; Thompson DD
    J Bone Miner Res; 2003 Nov; 18(11):2033-42. PubMed ID: 14606517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells' activity.
    Serra-Pages M; Torres R; Plaza J; Herrerias A; Costa-Farré C; Marco A; Jiménez M; Maurer M; Picado C; de Mora F
    Clin Exp Allergy; 2015 Oct; 45(10):1590-600. PubMed ID: 25823713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor.
    Tilley SL; Audoly LP; Hicks EH; Kim HS; Flannery PJ; Coffman TM; Koller BH
    J Clin Invest; 1999 Jun; 103(11):1539-45. PubMed ID: 10359563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
    Qiu J; Li Q; Bell KA; Yao X; Du Y; Zhang E; Yu JJ; Yu Y; Shi Z; Jiang J
    Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.